PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration for Targeted Alpha Therapy Candidate NUVL Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher as Pipeline Progress Drives Optimism Stock Market Climbs Wall of Worry Resilience in the Face of Geopolitical Uncertainty RenovoRx RNXT Q1 2026 Earnings WiderthanExpected Loss and Stock Decline Amid PreRevenue Stage Clear Channel Outdoor Holdings Inc CCO Q1 2026 Earnings EPS Slightly Beats Estimates Amid Revenue Discretion Genesis Energy LP GEL Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Market Conditions International Paper IP Q1 2026 Earnings Modest EPS Beat Sustains Positive Traction First Mid Bancshares Inc Q1 2026 Earnings EPS Beat Driven by Strong Net Interest Income IBM Q1 2026 Earnings Earnings Per Share Beat Estimates Stock Rises OTF Q1 2026 Earnings Massive EPS Miss Amidst Portfolio Losses HCM Q2 2023 Earnings EPS Surges Past Estimates as Operating Performance Improves Allogene Therapeutics Inc ALLO Q1 2026 Earnings Narrower Loss Surprises Analysts as Cell Therapy Pipeline Advances